Human Immune Repertoire Antibody Library

Human Immune Repertoire Antibody Library

BioPharma Human Immune Repertoire Antibody Library Human antibody repertoires offer vast therapeutic potential, yet most libraries derive from infected or immunized donors, limiting diversity and stability. Antibodies from naturally resilient individuals provide...
Synthetic Human Antibody Library for Broad Target Screening

Synthetic Human Antibody Library for Broad Target Screening

BioPharma Synthetic Human Antibody Library for Broad Target Screening Monoclonal antibody therapeutics are among the most successful drug classes, yet traditional discovery methods rely on immunisation or donor-derived B-cell repertoires. These approaches can be slow,...
Predicting Pre-Eclampsia

Predicting Pre-Eclampsia

BioPharma Predicting Pre-Eclampsia Pre-eclampsia, a condition affecting pregnant women, remains poorly understood despite affecting up to one in ten pregnancies worldwide. The condition kills 70,000 mothers and half a million babies globally each year. If diagnosed...
Predicting dementia nine years before symptoms

Predicting dementia nine years before symptoms

BioPharma Predicting dementia nine years before symptoms Researchers at Queen Mary’s Centre of Preventive Neurology have developed a new method for predicting dementia with over 80% accuracy and up to nine years before a diagnosis. The new method provides a more...
Diagnosing type 1 diabetes using insulin neoepitopes

Diagnosing type 1 diabetes using insulin neoepitopes

BioPharma Diagnosing type 1 diabetes using insulin neoepitopes Diabetes is one of the most common chronic diseases in Britain – and is getting ever more prevalent. Although less than one in ten diabetes patients have type 1 diabetes, it is much more common among...